the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email .

Share this:
Brief Title Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody
Official Title A First-in-Human Phase 1 Dose Escalation Trial of Hu5F9-G4 in Patients With Advanced Solid Malignancies
Principal Investigator Fleming, Gini
Brief Summary The purpose of this study is to assess the safety and tolerability of Hu5F9-G4 in participants with solid tumors.
Gender All
Ages 18 Years
Enrollment 96
Accepts Healthy Volunteers No
Lead Sponsor Forty Seven, Inc.Industry
Study Design
Study Phase Phase 1
Study Type Interventional
Contact Name
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Solid Tumor
Detail for Health Professional (on
More clinical trials by this PI